Constipation X-ray: Procedure, results, and treatment

Translate to Spanish or other 102 languages!

An abdominal X-ray of someone with suspected severe constipation can help doctors assess the person’s digestive system and create a treatment plan. Image for illustration purposes
An abdominal X-ray of someone with suspected severe constipation can help doctors assess the person’s digestive system and create a treatment plan. Image for illustration purposes

Medical News Today

- Advertisement -

An abdominal X-ray of someone with suspected severe constipation can help doctors assess the person’s digestive system and create a treatment plan.

Constipation can happen to anyone for many different reasons. The longer stool remains in the digestive tract, the harder feces become. A person who has had fewer than three bowel movements per weekTrusted Source may be constipated.

People who experience constipation may notice the following symptoms:

- Advertisement -
  • lower back pain
  • pain in the abdomen
  • painful stools
  • inability to pass gas
  • incomplete passing of stools

Follow the kink below to Medical News Today to read the full Story:

https://www.medicalnewstoday.com/articles/constipation-x-ray?utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2023-03-14&apid=&rvid=079da5ada992cf89183b8daba474d846b774c1cab825a30c1edc4e1bd42a6b12

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Authorizes First Wearable Device that Continuously Monitors Both Ketone Levels and Blood Sugar

The U.S. Food and Drug Administration today authorized the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for people aged 2 years and older living with diabetes.

Golden Years, Restless Nights: How Aging Transforms Your Sleep Cycles

If you have trouble falling asleep or staying asleep, your age could be playing a role.

FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer

The U.S. Food and Drug Administration approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients with advanced pancreatic cancer months ahead of schedule. 

STHS Behavioral’s Webinar on Suicide Prevention Awareness, Sept. 3rd

More than 49,000 people died by suicide in the United States in 2023, according to the Centers for Disease Control and Prevention (CDC), making it one of the leading causes of death among adolescents and adults.
- Advertisement -